THOMAS JEFFERSON UNIVERSITY DEPARTMENT OF RADIATION ONCOLOGY

ACCOMPLISHMENTS REPORT

JULY 1, 2015 – DECEMBER 31, 2016 (for the period ending October 31, 2016)

Bold = Member of the Department of Radiation Oncology

PUBLICATIONS

1. Ahn PH, Machtay M, Anne` PR, Cognetti D, Keane WM, Wuthrick E, Dicker AP, Axelrod RS: Phase I trial using induction Ciplatin, Docetaxel, 5-FU and Erlotinib followed by Cisplatin, Bevacizumab aNd Erlotinib with concurrent radiotherapy for advanced head and neck cancer. Am J Clin Oncol. 2016 Jul 7. [Epub ahead of print]. PMID: 27391356

2. Alexander GS, Palmer JD, Tuluc M, Lin J, Dicker AP, Bar Ad V, Harshyne LA, Louie J, Shaw CM, Hooper DC, Lu B: Immune biomarkers of treatment failure for a patient on a phase I clinical trial of pembrolizumab plus radiotherapy. J Hematol Oncol. 2016 Sep 23;9(1):96. PMID: 27663515

3. Bar-Ad V, Zhang QE, Harari PM, Axelrod R, Rosenthal DI, Trotti A, Jones CU, Garden AS,

Song G, Fotte RL, Raben D, Shenouda G, Spencer SA, Harris J, Le QT: Correlation between the severity of Cetuximab-induced skin rash and clinical outcome for head and neck cancer patients: The RTOG experience. Int J Radiat Oncol Biol Phys. 2016 Aug 1;95(5):1346-54. PMID: 27212198

4. Bovenzi CD, Hamilton J, Tassone P, Johnson J, Cognetti DM, Luginbuhl A, Keane WM, Zhan T, Tuluc M, Bar-Ad V, Martinez-Outschoorn U, Curry JM: Prognostic indications of elevated MCT4 and CD147 across cancer types: A meta-analysis. Biomed Res Int. 2015;2015:242437. Epub 2015 Dec 8. PMID: 26779534

5. Caine C, Deshmukh S, Gondi V, Mehta M, Tome W, Corn BW, Kanner A, Rowley H, Kundapur V, DeNittis A, Greenspoon JN, Konski AA, Bauman GS, Raben A, Shi W, Wendland M, Kachnic L: CogState computerized memory tests in patients with brain metastases: secondary endpoint results of NRG Oncology RTOG 0933. J Neurooncol. 2016 Jan;126(2):327-36. PMID: 26511494.

6. Chapman KL, Witek ME, Chen H, Showalter TN, Bar-Ad V, Harrison AS: Pancreatic cancer planning: Complex conformal vs. modulated therapies. Med Dosim. 2016 Summer;41(2):100-4. 26831922

7. Chen YW, Mahal BA, Muralidhar V, Nezolosky M, Beard CJ, Den RB, Feng FY, Hoffman KE, Martin NE, Orio PF, Nguyen PL: Association between treatment at a high-volume facility and improved survival for radiation-treated men with high-risk prostate cancer. Int J Radiat Oncol Biol Phys. 2016 Mar 15;94(4):683-90. PMID: 26972640

8. Chernets N, Kurpad DS, Aleexev V, Rodrigues DB, Freeman TA: Reaction chemistry generated by nanosecond pulsed dielectric barrier discharge treatment is responsible for the tumor eradication in the B16 melanoma mouse model. Plasma Processes Polym. Oct 2015;12(12):1400-09.

9. Dan TD, Doyle L, Raval AJ, Pridjian A, Gomella LG, Den RB: Dosing, administration, and safety of radium-223: How I do it. Can J Urol. 2016 Jun;23(3):830-5. PMID: 27347625

10. Den RB, Santiago-Jimenez M, Alter J, Schliekelman M, Wagner JR, Renzulli JF, Lee DI, Brito CG, Monahan K, Gburek B, Kella N, Vallabhan G, Abdollah F, Trabulsi EJ, Lallas CD, Gomella LG, Woodlief TL, Haddad Z, Lam LL, Deheshi S, Wang Q, Choeurng V, duPlessis M, Jordan J, Parks B, Shin H, Buerki C, Yousefi K, Davicioni E, Patel VR, Shah NL: Decipher correlation patterns post prostatectomy: Initial experience from 2,342 prospective patients. Prostate Cancer Prostatic Dis. 2016 Dec;19(4):374-70. PMID: 27574020

11. Doyle LA, Yondorf M, Peng C, Harrison SA, Den RB: Process mapping and time study to improve efficiency of new procedure implementation for high dose rate prostate brachytherapy. J Healthc Qual. Nov. 1 [Epub ahead of print]. PMID: 27811578

12. Du S, Lockamy V, Zhou L, Xue C, LeBlanc J, Glenn S, Shukla G, Yu Y, Dicker AP, Leeper DB, Lu Y, Lu B: Stereotactic body radiation therapy delivery in a genetically engineered mouse model. Int J Radiat Oncol Biol Phys. 2016 Nov 1;96(3):529-37. PMID: 27681749

13. Evans JR, Zhao SG, Chang SL, Tomlins SA, Erho N, Sboner A, Schiewer MJ, Spratt DE, Kothari V, Klein EA, Den RB, Dicker AP, Karnes RJ, Yu X, Nguyen PL, Rubin MA, deBono J, Knudsen KE, Davicioni E, Feng FY: Patient-level DNA damage and repair pathway profiles and prognosis after prostatectomy for high-risk prostate cancer. JAMA Oncol. 2016 Apr 1;2(4):471-80. PMID: 26746117

14. Faisal FA, Sundi D, Tosoian JJ, Choeurng V, Alshalalfa M, Ross AE, Klein EA, Den RB, Dicker AP, Erho N, Davicioni E, Lotan TL, Schaeffer EM: Racial variations in prostate cancer molecular subtypes and androgen receptor signaling reflect anatomic tumor location. Euro. Urol. 2016 Jul;70(1):14-7. PMID: 26443432.

15. Freedland SJ, Choeurng V, Howard L, De Hoedt A, du Plessis M, Yousefi K, Lam LL, Buerki C, Ra S, Robbins B, Trabulsi EJ, Shah NL, Abdollah F, Feng FY, Davicioni E, Dicker AP, Karnes RJ, Den RB: Utilization of a genomic classifier for prediction of metastasis following salvage radiation therapy after radical prostatectomy. Euro Urol. 2016 Jan 21.[Epub ahead of print]. PMID: 26806658

16. Freedland SJ, Den RB: Reply to Nicola Fossati, Giorgio Gandaglia, Alberto Bossi, Francesco Montorsi, Alberto Briganti’s Letter to the Editor re: Stephen J. Freedland, Voleak Choeurng, Lauren Howard et al. Utilization of a genomic classifier for prediction of metastasis following salvage radiation therapy after radical prostatectomy. Eur Urol. In press. Eur Urol. 2016 Mar 15 [Epub ahead of print]. PMID: 26992279

17. Giaddui T, Chen W, Yu J, Lin L, Simone CB 2nd, Yuan L, Gong YU, Wu QJ, Mohan R, Zhang X, Bluett JB, Gillin M, Moore K, O’Meara E, Presley J, Bradley JD, Liao Z, Galvin J, Xiao Y: Establishing the feasibility of the dosimetric compliance criteria of RTOG 1308: Phase III randomized trial comparing overall survival after photon versus proton radiochemotherapy for inoperable stage II-IIIB NSCLC. Radita Oncol. 2016 May 4;11:66. PMID: 27142674

18. Giaddui T, Yu, J, Manfredi D, Linnenmann N, Hunter J, O’Meara E, Galvin J, Bialecki B, Xiao Y: Structures’ validation profiles in transmission of imaging and data (TRIAD) for automated National Clinical Trials Network (NCTN) clinical trial digital data quality assurance. Practical Radiation Oncology, 2016, Jan 21. [Epub ahead of print}. PMID: 27053498

19. Giaddui T, Yu J, Doemer A, Matuszak M, Nunez F, Vineberg K, Xia P, Yom SS, Xiao Y: A feasibility study of the dosimetric compliance criteria of the NRG-HN002 head and neck clinical trial across different radiotherapy treatment planning systems and delivery techniques: A model for optimizing initial trial launch. Accepted, Journal of Cancer Prevention and Current Research, October, 2016.

20. Gilani M, Williams NL, Giordano C, Rosenblum N, Shi W, Anne` PR, Schilder R: Brain metastases in patients with gynecologic cancers: A single institution experience and review of the literature. Open Journal of Obstetrics and Gynecology, 2016, 6:544-52.

21. Glass J, Won M, Schultz CJ, Brat D, Bartlett NL, Suh JH, Werner-Wasik M, Fisher BJ, Liepman MK, Augspurger M, Bokstein F, Bovi JA, Solhjem MC, Mehta MP: Phase I and II study of induction chemotherapy with methotrexate, rituximab, and temozolomide followed by whole-brain radiotherapy and postirradiation temozolomide for primary CNS. Lymphoma: NRG Oncology RTOG 0227. J Clin Oncol. 2016 May 10;34(14):1620-5. PMID: 27022122

22. Gochoco A, Jones E, Soutendijk C, Alpdogan O, Shi W, Sahu J: Amlodipine-induced hypersensitivity reaction mimicking CD30(+) mycosis fungoides. JAAD Case Report 2016 Aug 17;2(4):320-2. PMID: 27570814

23. Goodwin JF, Kothari V, Drake JM, Zhao S, Dylgjeri E, Dean JL, Schiewer MJ, McNair C,

Jones JK, Aytes A, Magee MS, Snook AE, Zhu Z, Den RB, Birbe RC, Gomella LG, Graham NA, Vashisht AA. Wohlschlegel JA,. Graeber TJ, Karnes RJ, Takhar M. Davicioni E, Tomlins SA, Abate-Shen C, Sharifi N, Witte ON, Feng FY, Knudsen KE: DNA-PKcs-mediated transcriptional regulation drives prostate cancer progression and metastasis. Cancer Cell. 2015 Jul 13;28(1):97-113. PMID: 26175416

24. Guo J, Zinner R, Zaorsky NG, Guo W, Lu B: Systemic therapy for echinoderm microtubule-associated protein-like 4 anaplastic lymphoma kinase non-small cell lung cancer brain metastases. J Thorac Dis. 2016 Sep;8(9):E1028-E1031. PMID: 27747054

25. Hoopes DJ, Dicker AP, Eads NL, Ezzell GA, Fraass BA, Kwiatkowski TM, Lash K, Patton GA, Piotrowski T, Tomlinson C, Ford EC: RO-ILS: Radiation Oncology Incident Learning System: A report from the first year of experience. Pract Radiat Oncol. 2015 Sept-Oct;5(5):312-8. PMID: 26362705

26. Hu BR, Fairey AS, Madhav A, Yang D, Li M, Groshen S, Stephens C, Kim PH, Virk N, Wang L, Martin SE, Erho N, Davicioni E, Jenkins RB, Den RB, Xu T, Xu Y, Gill IS, Quinn DI, Goldkorn A: AXIN2 expression predicts prostate cancer recurrence and regulates invasion and tumor growth. Prostate. 2016 May;76(6):597-608. PMID: 26771938

27. Jiang S. Lou J, Yang Z, Dai J, Yu Y: Design, analysis and control of a novel tendon-driven magnetic resonance-guided robotic system for minimally invasive breast surgery. Proc Inst Mech Eng Part H: Journal of Engineering in Medicine, 2015 Sep;229(9):652-69. PMID: 26334035

28. Jiang S. Ma X, Yu Y, Yang Z: Accurate error compensation or a MR-compatible surgical robot based on a novel kinematic calibration method. Advanced Robotics, 2015, Sept:29(18):1183-94.

29. Johnson JM, Lai SY, Cotzia P, Cognetti D, Luginbuhl A, Pribitkin EA, Zhan T, Mollaee M, Domingo-Vidal M, Chen Y, Campling B, Bar-Ad V, Birbe R, Tuluc M, Martinez Outschoorn U,

Curry J: Mitochondrial metabolism as a treatment target in anaplastic thyroid cancer. Semin Oncol. 2015 Dec;42(6):915-22. PMID: 26615136

30. Kim ES, Bernstein D, Hiulsenbeck SG, Chung CH, Dicker AP, Ersek JL, Stein S, Khuri FR, Burgess E, Hunt K, Ivy P, Bruinooge SS, Meropol N, Schilsky RL: Modernizing eligibility criteria for molecularly driven trials. J Clin Oncol. 2015 Sep 1;33(25):2815-20. PMID: 26195710.

31. Kim H, Alshalalfa M, Hoffman-Censits J, Lallas CD, Davicioni E, Lin J, Birbe R, Erho N, Lehrer J, Ashab HA, Takhar M, Olson A, Lam LL, Kelly WK, Knudsen KE, Thangavel C, Seiler R, Feng FY, Schaeffer EM, Trabulsi EJ, Gomella LG, Hurwitz MD, Dicker AP, Den RB: Potential impact on clinical decision making via a genome-wide expression profiling: A case report. Urol Cse Rep. 2016 Oct 1;9:51-54. PMID: 27713863

32. Kim H, Bar Ad V, McAna J, Dicker AP: Evaluating the quality, clinical relevance, and resident perception of the radiation oncology in-training examination: A national survey. Pract Radiat Oncol. 2016 Jan-Feb;6(1):44-9. PMID: 26577011

33. Kim H, Dan TD, Palmer JD, Leiby BE, Lawrence YR, Dicker AP: Quality and reporting accuracy of Phase 1 drug radiation clinical trials. JAMA Oncol. 2016 Mar 1;2(3):390-1. PMID: 26841256

34. Kim H, Leiby BE, Shi W: Too little, too soon: Short-course radiotherapy in elderly patients with glioblastoma. J Clin Oncol. 2016 Jun 20;34(18):2191-92. PMID: 27069070

35. Kim H, Malatesta T, Simone N, Den R, McAna J, Dicker AP, Bar Ad V: A single activity with a practice quality improvement project for faculty and a quality improvement project for residents. Pract Radiat Oncol 2016 Mar-Apr;6(2):114-8. PMID: 26723550

36. Kim H, Skowronski J, Den RB: Prognostic outlier genes for enhanced prostate cancer treatment. Future Oncol. 2016 Oct. 12. [EPub ahead or print]. PMID: 27728977

37. Kleinberg LR, Catalano PJ, Forastiere AA, Keller SM, Mitchell EP, Anne` PR, Benson AB 3rd: Eastern Cooperative Group and American College of Radiology Imaging Network randomized phase 2 trial of neoadjuvant preoperative paclitaxel/cisplatin/radiation therapy (RT) or irinotecan/cisplatin/RT in esophageal adenocarcinoma: Long-term outcome and implications for trial design. Int J Radiat Oncol Biol Phys. 2016 Mar 15;94(4):738-46. PMID: 26972646

38. Klein EA, Santiago-Jimenez M, Yousefi K, Robbins BA, Schaeffer EM, Trock NJ, Tosoian J, Haddad Z, Ra S, Karnes RJ, Jenkins RB, Cheville JC, Den RB, Dicker AP, Davicioni E, Freedland SJ, Ross AE: Molecular analysis of low grade prostate cancer utilizing a genomic classifier of metastatic potential. J Urol. 2016 Aug 25 [Epub ahead of print]. PMID: 27569435

39. Klement RJ, Belderbos, Grills I, Werner-Wasik M, Hope A, Giuliani M, Ye H, Sonke JJ, Peulen H, Guckenberger M: Prediction of early death in patients with early-stage NCSCL – Can we select patients without a potential benefit of SBRT as a curative treatment approach: J Thorac Oncol. 2016 Apr 7. Jul;11(7):1132-9. PMID: 27060654

40. Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, …Lu B,…Zughaier SM: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 2016 Jan 2;12(1):1-222. PMID: 26799652

41. Kok HP, Wust P, Stauffer PR, Badati F, van Rhoon GC, Crezee J: Current state of the art of regional hyperthermia treatment planning: a review. Radiat Oncol. 2015 Sept 17;19(1):196. PMID: 26383087

42. Kukielka AM, Strnad V, Stauffer P, Dabrowski T, Hetnal M, Nahajowski D, Walasek T, Brandys P, Matys R: Salvage brachytherapy in combination with interstitial hyperthermia for locally recurrent prostate carcinoma following external beam radiation therapy: a prospective phase II study. J Contemp Brachytherapy. 2015 Jun;7(3):254-8. PMID: 26207116

43. Lewis MA, Dicker AP: Social Media and Oncology: The past, present and future of electronic communication between physician and patient. Semin Oncol. 2015 Oct;42(5):764-71. PMID: 26433557

44. Li J, Harrison A, Yu Y, Xiao Y, Werner-Wasik M, Lu B: Evaluation of Elekta 4D cone-beam CT based automatic image registration for radiation treatment of lung cancer. Br J RadioL. 2015 Sep;88(1053):20140620. Epub 2015 Jul 17. PMID: 26183932

45. Li P, Jiang S. Yu Y, Yang J, Yang Z: Biomaterial characteristics and application of silicone rubber and PVA hydrogels mimicked in organ groups for prostate brachytherapy. J Mech Benav Biomed Mater. 2015 Sep; 49:220-34. PMID: 26042767

46. Liu H, Andrews DW, Evans JJ, Werner-Wasik M, Yu Y, Dicker AP, Shi W: Plan quality and treatment efficiency for radiosurgery to multiple brain metastases: Non-Coplanar RapidArc vs. Gamma Knife. Front Oncol. 2016 Feb 11;6:26. PMID: 26904504

47. Liu H, Li J, Pappas E, Andrew D, Evans J, Werner-Wasik M, Yu Y, Dicker AP, Shi W: Dosimetric validation for an automatic brain metastases planning software using single-isocenter dynamic conformal arcs Dosimetric validation for an automatic brain metastases planning software using single-isocenter dynamic conformal arcs. J App Clin Med Phys. 2016 Sep 8;17(5):6320. PMID: 27685134

48. Maccarini PF, Shah A. Palani SY, Pearce DV, Vardhan M, Stauffer PR, Rodrigues DB, Salahi S, Oliveira TR, Reudink D, Snow BW: A novel compact microwave radiometric sensor to noninvasively track deep tissue thermal profiles. Proceedings of the IEEE: 2015 European Microwave Week, September 6-11, 2015, Paris, France.

49. Miyahira AK, Lang JM, Den RB, Garraway IP, Lotan TL, Ross AE, Stoyanova T, Cho SY, Simons JW, Pienta KJ, Soule HR: Multidisciplinary intervention of early, lethal metastatic prostate cancer: Report from the 2015 Coffee-Holden Prostate Cancer Academy Meeting. Prostate. 2016 Feb;76(2):125-39. PMID: 26477609.

50. Myers RE, Leader AE, Censits JH, Trabulsi EJ, Keith SW, Petrich AM, Quinn AM, Den RB, Hurwitz MD, Lallas CD, Hegarty SE, Dicker AP, Zeigler-Johnson CM, Giri VN, Ayaz H, Gomella LG: Decision support and shared decision making about active surveillance versus active treatment among men diagnosed with low-risk prostate cancer: A pilot study. J Cancer Educ 2016 Jul 15 [Epub ahead of print]. PMID: 27418065

51. Nowak K, Bar Ad V, Ferguson L, McAna J, Harrison AS, Yu Y, Doyle L: Using the ACR accreditation process as a quality improvement tool. J Am Coll Radiol. 2016 Jul;13(7):881-3. PMID: 26908397

52. Ohri N, Duan F, Snyder BS, Wei B. Machtay M, Alavi A, Siegel BA, Johnson DW, Bradley JD, DeNittis A, Werner-Wasik M, El Naqa I: Pretreatment 19FDG-PET textural features in locally advanced non-small cell lung cancer: Secondary analysis of ACRIN 6668/RTOG 0235. J Nucl Med. 2016 Jun;57(6):842-8. PMID: 26912429

53. Orlando MF, Kumar M, Franz K, Kohn B, Hutapea P, Zhao Y, Dicker AP, Yu Y, Podder T: Control of shape memory alloy actuated flexible needle using multimodal sensory feedbacks. J. Automation and Control Engineering. 2015 Oct;3(5):428-34.

54. Ozdemir A, Yegingil Z, Nur N, Kurt K, Tuken T, Depci T, Tansug G, Altunal V, Guckan V,.Sigircik G, Yu Y, Karatasli M, Dolek Y: Thermoluminescence study of Mn doped lithium tetraborate powder and pellet samples synthesized by solution combustion synthesis. Journal of Luminescence 173 (2016): 149-58.

55. Parekh A, Nguyen PL, West LJ, Duarte C, Graham PL, Larock DR, Yeung V, Hurwitz MD: Feasibility of brachytherapy as monotherapy for high-volume, low-risk prostate cancer. J Cancer Res Ther. 2016 Jan-Mar;12(1):406-10. PMID: 27072271

56. Perepelyuk M, Thangavel C, Liu Y, Den RB, Lu B, Snook AE, Shoyele SA: Biodistribution and phar`macokinetics study of siRNA-loaded Anti-NTSR1-mAb-functionalized novel hybrid nanoparticles in a metastatic orthotopic murine lung cancer model. Mol Ther Nucleic Acids. 2016 Jan 26;5:e282. PMID: 26812654

57. Peulen H, Mantel F, Guckenberger M, Belderbos J, Werner-Wasik M, Hope A, Giuliani M, Grills I, Sonke JJ: Validation of high-risk computed tomography features for detection of local recurrence after stereotactic body radiation therapy for early-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2016 Sep 1;96(1):134-41. PMID: 27325481

58. Pisansky TM, Agrawal S, Hamstra DA, Koontz BF, Liauw SL, Efstathiou JA, Michalski JM, Feng FY, Abramowitz MC, Pollack A, Anscher MS, Moghanaki D, Den RB, Stephans KL, Zietman AL, Lee WR, Kattan MW, Stephenson AJ, Tendulkar RD: Salvage radiation therapy dose response for biochemical failure of prostate cancer after prostatectomy – A multi-institutional observational study. Int J Radiat Oncol Biol Phys. 2016 Sep 3 [Epub ahead of pirnt]. PMID: 27745980

59. Rodrigues DB, Stauffer PR, Colebeck E, Hood AZ, Salahi S, Maccarini PF, Tapsakal E: Dielectric properties measuremetns of brown and white adipose tissue in rates from 0.5 to 10 GHz. Biomed Phys Eng Express. 2016 [Epub ahead of print].

60. Roesch J, Stam B, Belderbos J, Peulen H, Flentje M, Giuliani M, Hope A, Werner-Wasik M,

Hong Y, Grills I: 99PD: Modelling of pulmonary function test changes after stereotactic body radiotherapy for stage I NSCLC. J ThoraC Oncol. 2016 April;11 (4 Suppl). [Epub ahead of print]. PMID: 27198240

61. Romero F, Shah D, Duong M, Penn RB, Fessler MB, Madenspacher J, Stafstrom W, Kavuru M, Lu B, Kallen CB, Walsh K, Summer R: A pneumocyte-macrophage paracrine lipid axis drives the lung toward fibrosis. Am J Respir Cell Mol Biol. 2015 Jul;53(1):74-86. PMID: 25409201

62. Ross AE, Den RB, Yousefi K, Trock BJ, Tosoian J, Davicioni E, Thompson DJ, Choeurng V, Haddad Z, Tran PT, Trabulsi EJ, Gomella LG, Lallas CD, Abdollah F, Feng FY, Klein EA, Dicker AP, Freedland SJ, Karnes RJ, Schaeffer EM: Efficacy of post-operative radiation in a

prostatectomy cohort adjusted for clinical and genomic risk. Prostate Cancer Prostatic Dis. 2016 Sep;19(3):277-82. PMID: 27136742

63. Sayeed A, Lu H, Liu Q, Deming li D, Duffy A, McCue P, Dicker AP, Davis RJ, Gabrilovich D, Rodeck U, Altieri DC. Languino LR: β1 integrin- and JNK-dependent tumor growth upon fractionated radiation. Oncotarget. 2016 Jul 11 [Epub ahead of print]. PMID 27438371

64. Schnipper LE, Daviodson NE, Wolins DS, Blayney DW, Dicker AP, Ganz PA, Hoverman JR, Langdon R, Lyman GH, Meropol NJ, Mulvey T, Newcomer L, Peppercorn J, Polite B, Raghavan D, Rossi G, Saltz L, Schrag D, Smith TJ, Yu PP, Hudis CA, Vose JM, Schilsky RL: Updating the American Society of Clinical Oncology value framework: Revisions and reflections in response to comments received. J Clin Oncol. 2016 May 31 [Epub ahead of print]. PMID: 27427218

65. Schooneveldt G, Bakker A, Balidemaj E, Chopra R, Crezee J, Geijsen ED, Hartmann J, Hulshof MC, Kok HP, Paulides MM, Sousa-Escandon A, Stauffer PR, Maccarini PF: Thermal dosimetry for bladder hyperthermia treatment. An overview. Int J Hyperthermia. 2016 June 32(4):417-33. PMID: 27132465

66. Shi W, Dicker AP: CNS metastases in patients with non-small-cell lung cancer and ALK gene rearrangement. J Clin Oncol. 2016 Jan 10;34(2):107-9. PMID: 26628475

67. Shi W, Jain V, Kim H, Camp C, Jain G, Farrell C, Andrews DW, Judy K, Liu H, Artz G, Werner-Wasik M, Evans JJ: Fractionated stereotactic radiotherapy for facial nerve schwannomas. J Neurol Surg B Skull Base. 2016 Feb;77(1):75-80. PMID: 26949592

68. Shi W, Palmer JD, Werner-Wasik M, Andrews DW, Evans JJ, Glass J, Kim L, Bar-Ad V, Judy K, Farrell C, Simone N, Liu H, Dicker AP, Lawrence YR: Phase I trial of panobinostat and fractionated stereotactic re-irradiation therapy for recurrent high grade gliomas. J Neurooncol. 2016 May;127(3):535-9. PMID: 26821711

69. Simone BA, Dan T, Palagani A, Jin L, Han SY, Wright C, Savage JE, Lim MK, Palazzo J, Mehta MP, Simone NL: Caloric restriction coupled with radiation decreases metastatic burden in triple negative breast cancer. Cell Cycle. 2016 Sep;15(17):2265-74. PMID: 27027731.

70. Stauffer PR, van Rhoon GC: Overview of bladder heating technology: matching capabilities

with clinical requirements. Int J Hyperthermia. 2016 Mar 32(4):407-16. PMID: 26939993

71. Stauffer PR, Vasilchenko IL, Osintsev AM, Rodrigues DB, Bar Ad V, Hurwitz MD, Kolomiets SA: Tumor bed brachytherapy for locally advanced laryngeal cancer: A feasibility assessment of combination with ferromagnetic hyperthermia. Biomedical Physics and Engineering Express. Sept. 5, 2016.

72. Tao Z, LeBlanc JM, Wang C, Zhan T, Ahuang H, Wang P, Yuan Z, Lu B: Coadministration of Trametinib and Palbociclib radiosensitizes KRAS-Mutant non-small cell lung cancers in vitro and in vivo. Clin Cancer Res. 2016 Jan 1;22(1):122-33. PMID: 26728409

73. Tendulkar RD, Agrawal S, Gao T. Efstathiou Jam Pisansky TM, Michalski JM,Koontz BF, Hamstra DA, Feng FY, Liauw SL, Abramowitz MC, Pollack A, Anscher MS,Moghanaki D, Den RB, Stephans KL, Zietman AL, Lee WR, Kattan MW, Stephenson AJ: Contemporary update

of a multi-institutional predictive nomogram for salvage radiotherapy after radical prostatectomy. J Clin Oncol. 2016 Aug 15 [Epub ahead of print]. PMID: 27528718

74. Toss A, Palazzo J, Berger A, Guiles F, Sendecki JA, Simone NL, Anne` PR, Avery T, Jaslow R, Lazar M, Tsangaris T, Cristofanilla M: Clinical-pathological features and treatment modalities associated with recurrence in DCIS and micro-invasive carcinoma: Who to treat more and who to treat less. Breast. 2016 Aug 6. [Epub ahead of print]. PMID: 27506636

75. Vrba D, Rodrigues DB, Vrba J, Stauffer PR: Metamaterial antenna arrays for improved uniformity of microwave hyperthermia treatments. Progress in Electromag Research. 156:1-12, 2016.

76. Wang J, Hu W, Peng J, Lu S, Zhao J, Xiao Y, Zhang Z: Identical quality assurance for volumetric modulated arc therapy in Elekta and Varian machines. Technol Cancer Res Treat. 2015 Aug;14(4);483-90. PMID: 26269610

77. Wang YA, Sun Y, LeBlanc JM, Solomides C, Zhan T, Lu B: Nitrilase 1 modulates lung tumor progression in vitro and in vivo. Oncotarget. 2016 Mar 10 [Epub ahead of print]. PMID: 26967383

78. White NM, Zhao SG, Zhang J, Rozycki EB, Dang HX, McFadden SD, Eteleeb AM, Alshalalfa M, Vergara IA, Erho N, Arbeit JM, Karnes RJ, Den RB, Davicioni E, Maher CA: Multi-institutional analysis shows that low PCAT-14 expression associates with poor outcomes in prostate cancer . Eur Urol. 2016 Jul 22. [Epub ahead of print]. PMID: 27460352

79. Williams, NL, Keller J, Kremmel E, Lockamy VL, Harrison AS, Shi W: Scalp-sparing total skin electron therapy in mycosis fungoides: Case report highlighting technique and outcome. Pract Radiat Oncol. 2016 Nov-Dec;6(6):439-441. PMID: 27156426

80. Wright C, Simone NL: Obesity and tumor growth: inflammation, immunity, and the role of a ketogenic diet. Curr Opin Clin Nutr Metab Care. 2016 Jul;19(4):294-9. PMID: 27168354

81. Yamoah K, Johnson MH, Choeurng V, Faisal FA, Yousefi K, Haddad Z, Ross AE, Alshalafa M, Den RB, Lal P, Feldman M, Dicker AP, Klein EA, Davicioni E, Rebbeck TR, Schaffer EM: Novel biomarker signature that may predict aggressive disease in African American men with prostate cancer. J Clin Oncol. 2015 Sep 1;33(25):2789-96. PMID: 26195723

82. Yang L, Wan J, Xiao S, Barkhouse D, Zhu J, Li G, Lu B, Zhang Z: BH3 mimetic ABT-737 sensitizes colorectal cancer cells to ixazomib through MCL-1 downregulation and autophagy inhibition. Am J Cancer Res 2016 Jun 1;6(6)1345-57. PMID: 17429848

83. You S, Knudsen BS, Erho N, Alshalalfa M, Takhar M, Al-Dee Ashab H, Davicioni E, Karnes RJ, Klein EA, Den RB, Ross AE, Schaeffer EM, Garraway IP. Kim J, Freeman MR: Integrated classification of prostate cancer reveals a novel luminal subtype with poor outcome. Cancer Res. 2016 Jun 14 [Epub ahead of print]. PMID: 27302169

84. Zaorsky NG, Engleston BL, Horwitz EM, Dicker AP, Nguyen PL, Showalter TN, Den RB: The missing pieces in reporting of randomized controlled trials of external beam radiation therapy dose escalation for prostate cancer. Am J Clin Oncol. 2016 Aug;39(4):321-6. PMID: 27322694

85. Zaorsky NG, Keith SW, Shaikh T, Nguyen PL, Horowitz EM, Dicker AP, Den RB: Impact of radiation therapy dose escalation on prostate cancer outcomes and toxicities. Am J Clin Oncol. 2016 Mar 24 [Epub ahead of print]. PMID: 27014930

86. Zaorsky NG, Ricco AG, Churilla TM, Horwitz EM, Den RB: ASTRO APEX® and RO-ILS™ are applicable to medical malpractice in radiation oncology. Future Oncol. 2016 Jul 29 [Epub ahead of print]. PMID: 27470145

87. Zhang I, Zaorsky NG, Palmer JD, Mehra R, Lu B: Targeting brain metastases in ALK-rearranged non-small-cell lung cancer. Lancet Oncol. 2015 Oct;16(13):e510-21. Review. PMID: 26433824

88. Zhao SG, Chang SL, Spratt DE, Erho N, Yu M, Ashab HA, Alshalalfa M, Speers C, Tomlins SA, Davicioni E, Dicker AP, Carroll PR, Cooperberg MR, Freedland SJ, Karnes RJ, Ross AE, Schaeffer EM, Den RB: Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis. Lancet Oncol. 2016 Nov; 17(11): 1612-1620. PMID: 27743920

89. Zhao SG, Evans JR, Kothari V. Sun G, Larm A, Mondine V, Schaeffer EM, Ross AE, Klein EA, Den RB, Dicker AP, Karnes RJ, Erho N, Nguyen PL, Davicioni E, Feng FY: The landscape of prognostic outlier genes in high-risk prostate cancer. Clin Cancer Res. 2016 Apr 1;22(7):1777-86. PMID: 26631616

90. Zhao YJ, Podder TK, Zhang YD, Konh, B, Honavar M, Hutapea P, Joseph, FOM, Dicker AP, Yu Y: Fast and robust motion planning for robot-assisted active flexible needle steering. In press, International Journal of Medical Robotics and Computer-Assisted Surgery, 2015.

91. Zhao YJ, Wu WQ, Zheng TD, Wang RX, Peng JC, Yu Y: 3D dynamic motion planning for robot-assisted cannula flexible needle insertion into soft tissue. International Journal of Robotic Systems, 2016, 13:1-11.

BOOKS: Quality and Safety in Radiation Oncology. Adam P. Dicker, Tim R. Williams, Eric C. Ford, Editors. Demos Medical, 2016. BOOK CHAPTERS: Doyle, LA, Harrison AS, Yu Y: Training: How to Teach Quality and Safety in Quality and Safety in Radiation Oncology. Adam P. Dicker, Tim R. Williams, Eric C. Ford, Editors. Demos Medical, 2016. Harrison AS, Doyle LA, Yu Y: Making Metrics Matter in Quality and Safety in Radiation Oncology. Adam P. Dicker, Tim R. Williams, Eric C. Ford, Editors. Demos Medical, 2016. Yu Y, Doyle L, Harrison AS: Error identification and analysis in Quality and Safety in Radiation Oncology. Adam P. Dicker, Tim R. Williams, Eric C. Ford, Editors. Demos Medical, 2016.

ABSTRACTS:

1. Agrawal S, Stephenson AJ, Michalski J, Efstathiou JA, Pisansky TM, Feng F, Hamstra DA, Koontz BF, Liauw S, Abramowitz MC, Pollack A, Anscher MS, Moghanaki D, Den RB, Stephans KL, Go T, Kattan M, Tendulkar RD: Prostate cancer-specific mortality and survival outcomes for salvage radiation therapy after radical prostatectomy. Int J Radiat Oncol Biol Phys. 23016 Oct 1;96(2S):S101. PMID : 27675527

2. Den RB, Davicioni E, Takhar M, Erho NG, Lam L, Ashab HA, Olson A, Dillon M, Yousefi K, Wood P, Alshalafa M: The frequency of drugable targets in localized prostate cancer: Initial analysis from a commercially available genomic expression database in urologic cancer. Int J Radiat Oncol Biol Phys. 2016. Oct 1;96(2S):E251-E252. PMID: 27674178

3. Den RB, Yousefi K, Trock B, Davicioni E, Tosoian J, Thompson D, Choeurng V, Haddad Z, Tran PT, Trabulsi E, Gomella LG, Lallas CD, Abdollah F, Feng FY, Dicker AP, Freedland SJ, Karnes JR, Schaeffer EM, Ross AE: Efficacy of postoperative radiation in a prostatectomy cohort adjusted for clinical and genomic risk. Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):S103-4. PMID: 27675531

4. Du S, Lockamy VL, Zhou L, Xue C, LeBlanc J, Yu Y, Dicker AP, Lu B: Stereotactic body radiation therapy (SBRT) using a Sarrp for treating and monitoring therapy response in spontaneous Kras-driven lung tumor model. Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):E441. PMID: 27674701

5. Du S, Zhou L, Shukla G, Wang N, Yang L, Ma X, Wang Y, Dicker AP, Lu Y, Lu B: Pharmacological inhibition of PD-1 exacerbates radiation-induced cardiac toxicity through cytotoxic T cell-mediated myocarditis. Int J Rdiat Oncol Biol Phys. 2016 Oct 1;96(2S):S88. PMID: 27676042

6. Feng FY, Karnes JR, Ashab HA, Trock B, Ross AE, Tsai H, Tosoian J, Erho NG, Alshalafa M, Choeurng V, Yousefi K, Abdollah F, Klein EA, Nguyen PL, Dicker AP, Den RB, Davicioni E, Jenkins RB, Lotan T, Schaeffer EM: Development and validation of genomic signature that predicts androgen deprivation therapy and treatment failure. Int J Radiat Oncol Biol Phys. 2016. Oct 1;96(2S):E221. PMID: 27674101

7. Giaddui T, Glock A, Bollinger D, Zhong H, Phillips H, Nunez F, Infante R, Hames S, Linneman N, Elder E, Chen J, Waldron JN, Trotti A, Thorstad WL, Schaner PE, Chakravarti A, Yom SS, Xia P, Xiao Y: Improving treatment planning quality, consistency and efficiency using rapid and autoplanning: A Feasibility study based on the NRG-HN002 clinical trial. Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):E653. PMID: 27675271

8. Gochoco A, Abidi N, Jennings T, Sahu J, Alpdogan S, Harrison AS, Lockamy VL, Shi W:

Initial clinical experience of short-course low-dose total skin electron beam irradiation (TSEBT) for patients with mycosis fungoides. Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):E497-498. PMID: 27674847

9. Gore EM, Hu C, Bar Ad V, Robinson CG, Wheatley MD, Bogart JA, Graces Y, Kavadi VS, Narayan S, Iyengar P, Witts JS, Welsh JW, Koprowski CD, Larner JM, Bradley JD: Impact of incidental cardiac radiation on cardiopulmonary toxicity and survival for locally advanced non-small cell lung cancer: Reanalysis of NRG Oncology/RTOG 0617 with centrally contoured cardiac structures. Int J Radiat Oncol Bil Phys. 2016 Oct 1;96(2S): S129-30. PMID: 27675596

10. Guo W, Du S, Yang L, Dicker AP, Lu B: Stat3 activation mediates stem cell, DNA repair, and

immunosuppressive properties in crizotinib-resistance ELM4-ALK-rearranged lung cancer. Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):S76-77. PMID: 27677011

11. Kachnic LA, Moughan J, Suntharalingam M, Ilson DH, Konski AA, Burrows W, Anker C, Bar Ad V, Thakrar HV, Hayes JP, Gore EM, Kavadi VS, Komaki RU, Raben A, Giguere JK, Pollock J, Greenberger JS, Videtic GM, Roof KS, Watkins Bruner D: Patient-reported outcomes (PROs) in NRG Oncology/RTOG 0436: A phase 3 trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for esophageal cancer treated without surgery. Int J Radiat Oncol Biol Phys. 2016 Oct 1:96(2S):S313. PMID: 27675900

12. Kalchman I, Eldredge-Hindy HB, Hegarty SE, Ashamlla M, Keith SW, Werner-Wasik M: A pilot study of FDG PET lung uptake after thoracic radiation therapy and new pulmonary symptoms. Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):E453. PMID: 27674733

13. Kim H, Kalchman I, Dan T, Zhan T, Werner-Wasik M: The influence of insurance policy on radiation oncology physician stereotactic body radiation therapy/stereotactic ablative radiation therapy use practices: A North American survey. Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):E402-403. PMID: 27674596

14. Kim H, Malatesta T. Bar Ad V, Anne` PR, McAna J, Den RB: Improving resident education by providing continuing medical education (CME) and self-assessment module (SAM) credit to faculty in resident didactic sessions. Int J Radiat Oncol Biol Phys. 2015 Oct 1;96(2S):E414. PMID: 27674629

15. Lan J, Li R, Deng L, Tang F. Xu H, Xue JX, Zhou L, Lu B, Dicker AP, Lu Y: Hypofractionated radiation therapy slashes the immunosuppressive activity on CD8±T cell in tumor microenvironment. Int J Radita Oncol Bil Phys. 2016 Oct 1;96(2S):S86. PMID: 27676038

16. Nowak K, Casey J, Chitale , Kalchmn I, Buss E, Keith SW, Hegarty SE, Curtis M, Solomides C, Shi W, Judy KD, Andrews DW, Farrell CJ, Werner-Wasik M: High KI67 labeling index in resected WHO grade 1 meningiomas correlates with a higher rate of recurrence. Int J Radiat Oncol Biol Phys. 2016. Oct 1;96(2S):E572. PMID: 27675049

17. Palmer JD, Shukla G, Bhamidipati D, Skowronski J, Kim H, Judy KD, Evans JJ, Farrell CJ, Andrews DW, Kim L, Glass J, Werner-Wasik M, Shi W: Early tumor progression prior to adjuvant therapy may predict survival in newly-diagnosed glioblastoma. Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):E117-118. PMID: 27673820

18. Ramey SJ, Abramowitz MC, Moghanaki D, Agrawal S, Efstathiou JA, Pisansky TM, Michalski JM, Koontz BF, Hamstra DA, Feng FY, Liauw S, Anscher MS, Pollack A, Den RB, Stephans KL, Kattan M, Gao T, Stephenson AJ, Tendulkar RD: Benefit of elective nodal irradiation and androgen deprivation therapy with postprostatectomy salvage radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):S102. PMID: 27675529

19. Simone BA, Dan T, Palagani A, DeAngelis T, Schiewer M, Knudsen KE, Dicker AP, Simone NL: Caloric restriction augments the molecular effects of radiation in both hormone-sensitive and hormone-insensitive prostate cancers by decreasing inflammation. Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):S76. PMID: 27676012

20. Spratt DE, Zhao SG, Chang SL, Cooperberg MR, Erho NG, Speers C, Mera R, Niknafs YS, Nguyen PL, Den RB, Dicker AP, Freedland SJ, Karnes RJ, Ross AE, Schaeffer EM, Davicioni E, Carroll P, Chinnaiyan A, Tomlins SA, Ross AE, Feng FY: Identification and validation of intrinsic subtypes of prostate cancer. Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S): S3-4. PMID: 27675894

21. Williams NL, Kim H, Eldredge-Hindy HB, Feeney KJ, Mastrangelo MJ, Sato T, Kim L, Evans JJ, Farrell CJ, Judy KD, Andrews DW, Dicker AP, Werner-Wasik M, Wuthrick EJ, Shi W: Phase I study of ipilimumab combined with whole-brain radiation therapy or radiosurgery for melanoma patients with brain metastases. Int J Rdiat Oncol Biol Phys. 2016 Oct 1;96(2S):S179. PMID: 27675720

22. Yao M, Zhang Q, Woods CR, Nguyen-Tan PF, Rosenthal DI, Garden AS, Thorstad WL, Anne` PR, Schultz CJ, Caudell JJ, Filion E, Ridge JA, Jones CU, Kim H, Yom SS, Raben D, Bonner JA, Machtay M, Harris J, Le QT: Intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy in head and neck squamous cell carcinoma: A pooled analysis of NRG Oncology/RTOG 0129 and 0522. Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):S116-117. PMID: 27675562

23. Yu J, Gong Y, Yuan L, Xue C, Chen W, Giaddui TG, Wu QR, Lukka H, Kudchadker R, Seawrd SA, Gopaul DD, Michalski JM, Kaplan ID, Beliveau-Nadeau D, Stall BR, Beyer DC, Ma CM, Dayes IS, Pinover WH, Xiao Y: Investigation into the fesibility of having uniform compliance dosimetric criteria criteria across radiation therapy treatment modalities for NRG Oncology/RTOG 0938 by using machine learning. Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):E230-231. PMID: 27674126

24. Zaorsky NG, Ricco A, Churilla TM, Horwitz EM, Den RB: Applying ASTRO APEx guidelines and RO-ILS to medical malpractice in radiation oncology. Int J Rdiat Oncol Biol Phys. 2016 Oct 1;96(2S):E540. PMID: 27674964

25. Zhao SG, Chang SL, Spratt DE, Erho NG, Yu M, Ashab HA, Yousefi K, Alshalafa M, Speers C, Tomlins SA, Den RB, Dicker AP, Freedland SJ, Karnes RJ, Ross AE, Schaeffer EM, Davicioni E, Nguyen PL, Feng FY: A 24-gene predictor of response to postoperative radiation therapy in prostate cancer. Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S): S104-105. PMID: 27675534

INVITED SPEAKER: 1. Den, RB: Novel therapies and role of radiation therapy in the management of men with

metastatic prostate cancer. Speaker, Education Session Number 22. 2015 Annual Meeting of the American Society for Radiation Oncology (ASTRO), October 18-21, San Antonio, TX.

2. Den, RB: Integration of molecular signatures and genomic classifiers, potential opportunities

for integration in the practice of Radiation Oncology. Panel Member. 2015 Annual Meeting of the American Society for Radiation Oncology (ASTRO), October 18-21, San Antonio, TX.

3. Den RB: GU-V-Post-prostatectomy radiation therapy. Who, When and How to treat.

Scientific Session NN. 2015 Annual Meeting of the American Society for Radiation Oncology (ASTRO), October 18-21, San Antonio, TX.

4. Den, RB: Biochemical Recurrence: Questions Abound. Presentation at the May 20, 2016 ”Amtrak Alliance” Meeting at Johns Hopkins University in Baltimore, MD.

5. Dicker A.P.: “Radio-immunotherapy strategies for advanced prostate cancer”. West China

School of Medicine, West China Hospital, Sichuan University, Chengdu China, July , 2015.

6. Dicker A.P.: “Radio-immunotherapy strategies for advanced prostate cancer”. Department of Radiation Oncology, Xijing Hospital, FMMU, Xi’an, Shaanxi, China, July , 2015.

7. Dicker AP: Incident learning and building a culture of safety, speaker, Panel #16. Topic:

Lessons learned from ROILS: A case-based panel discussion. 2015 Annual Meeting of the American Society for Radiation Oncology (ASTRO), October 18-21, San Antonio, TX.

8. Dicker AP: Integration of molecular signatures and genomic classifiers, potential

opportunities for integration in the practice of radiation oncology. Panel Moderator, 2015 Annual Meeting of the American Society for Radiation Oncology (ASTRO), October 18-21, San Antonio, TX.

9. Dicker AP: Grand Rounds at North Shore-Long Island Jewish Hospital, May 27, 2016, New York, NY

10. Dicker AP, Doyle L, Yu Y: Moderator/Speaker/Session Creator of Panel session: RO-ILS and APEx: Instruments for quality improvement. 2016 Annual Meeting of the American Society for Radiation Oncology (ASTRO), September 25-28, 2016, Boston, Mass.

11. Dicker AP, Vikram B: Moderators of Panel session: Optimizing clinical trials in radiation oncology through public/private collaboartions. 2016 Annual Meeting of the American Society for Radiation Oncology (ASTRO), September 25-28, 2016, Boston, Mass.

12. Dicker AP: Discussant in e-Poster 14 Session: Biology – Translational Research: Risk stratification and prediction of response. 2016 Annual Meeting of the American Society for Radiation Oncology (ASTRO), September 25-28, 2016, Boston, Mass.

13. Gressen EL: Moderator for Panel, History Committee Educational Session: The marked impact of the patterns of care studies (PCS) on our present treatment and ties to prospective randomized trials. 2016 Annual Meeting of the American Society for Radiation Oncology (ASTRO), September 25-28, 2016, Boston, Mass.

14. Hurwitz M.: “Thermal Oncology”, Cancer Treatment Centers of America, Tulsa, OK, July 24, 2015.

15. Hurwitz M: Grand Rounds Speaker at Methodist Hospital: Hyperthermia Update: Focus on

the Thomas Jefferson Thermal Oncology Program, March 17, 2016, Philadelphia, PA.

16. Hurwitz M: Phase II-III trial of adjuvant radiotherapy following radical prostatectomy + adjuvant chemotherapy. Presentation at NRG Oncology Semi-Annual Meeting, July 14-17, 2016, Dallas Texas.

17. Khariton A: Cost to deliver care: Understanding radiation oncology economics (Oral

presentation). Society for Radiation Oncology Administrators Meeting, October 18, San Antonio, TX.

18. Rodrigues, D: “The use of microwage radiometry for noninvasive tracking of deep tissue thermal profiles. Working Group Meeting 2 of BMBS COST Action TD1301: Development of a European-based Collaborative Network to Acceleraet Technological, Clinical and Commercialisation Progress in the Area of Medical Microwave Imaging. October 1, 2015, Athens, Greece.

19. Rodrigues D: Clinical applications of microwave radiometry. IEEE Night, Philadelphia

Section Meeting, November 17, 2015, Philadelphia, PA

20. Shi W: Visiting Professor, Department of Radiation Oncology, University of Washington, December 9-10, 2015, Seattle, WA.

21. Shi, W: Invited Speaker, Jefferson Pituitary Symposium. Topics: “Radiation Treatment

Cushing’s Disease – A Radiation Oncologist’s perspective: and “Radiation for non-functional pituitary adenoma”, April 8, 2016, Philadelphia, PA.

22. Werner-Wasik, M.: Modern Approaches to Radiation Therapy Stage III Non-small Cell Lung

Cancer. 16th World Conference on Lung Cancer, Denver, CO, September 8, 2015.

23. Werner-Wasik, M.: Visiting Professor, SBRT for early stage non-small cell lung cancer. Department of Radiation Oncology, Hahnemann University Hospital, Philadelphia, PA, February 17, 2016.

24. Werner-Wasik, M: Medically Operable NSCLC: Wedge vs. stereotactic body radiation therapy. Annual Lung Cancer Symposium, Philadelphia, PA, March 11, 2016.

25. Werner-Wasik M: Acromegaly and Prolactinoma. Jefferson Pituitary Symposium: Controversies and Contemporary Management of Pituitary Disorders, Philadelphia, PA, April 8, 2016.

26. Werner-Wasik, M: SBRT for Lung Cancer. American Radium Society Annual Meeting, SBRT Primer Course, Philadelphia, PA, April 16, 2016.

27. Werner-Wasik M: Discussant at Oral Lung Scientific Session, “What happens when protons meet randomization”. 2016 ASCO Annual Meeting, Chicago, June 3-7, 2016.

28. Werner-Wasik, M: Panelist, “Highlights of radiation oncology: ASCO 2016”. Presented as an International Association for the Study of Lung Cancer (IASLC) Webinar, July 7, 2016.

29. Werner-Wasik M: Oral Session Moderator, Scientific Session 39: Lung-

toxicity/Miscellaneous. 2016 Annual Meeting of the American Society for Radiation Oncology (ASTRO), September 25-28, 2016, Boston, Mass.

30. Xiao Y.: Implementing SBRT Protocols: A NRG CIRO Perspective. 2015 Meeting of the

AAPM, July 12-16, Anaheim, CA

31. Yu, Y.: Medical physics research at Thomas Jefferson University. UT Southwestern Medical Center, September 10, 2015, Dallas, TX.

32. Yu, Y: Evaluation of robotic tracking system for motion compensation in radiation therapy. 15th IEEE International Conference on Bioinformatics and Bioengineering (BIBE). Conference Full Paper presentation, November 2-4, 2015, Belgrade, Serbia.

PRESENTATIONS:

1. Bruner DW, Deshmukh S, Michalski J, Purdy J, Bosch W, Bahary JP, Patel M, Parliament M, Lock M, Lau HY, Hamstra D, Fisher SA, Souhami L, Kwok Y, Seider M, Vigneault E, Gay H, Rosenthal S, Sandler H, Movsas: Bowel and bladder function of men on a Phase III randomized study of high versus standard dose 3D-CRT/IMRT in patients treated for localized prostate cancer. E-poster discussion presentation (#1103), 2015 Annual Meeting of the American Society for Radiation Oncology (ASTRO), October 18-21, San Antonio, TX.

2. Dan, T, Palagani A, Jin L, DeAngelis T, Wickstrom E, Simone NL: miR-21 modulates mammary tumorigenesis and radiosensitivity in a novel transgenic murine model. ePoster Discussion, 2015 Annual Meeting of the American Society for Radiation Oncology (ASTRO), October 18-21, San Antonio, TX.

3. Den RB, Choeurng V, Howard L, DeHoedt A, duPlessis M, Yousefi K, Lam L, Buerki C, Trabulsi E, Dicker AP, Davicioni E, Karnes JR, Freedland S: Validation of a genomic classifier for prediction of metastasis following postoperative salvage radiation therapy. Oral Presentation, 2015 Annual Meeting of the American Society for Radiation Oncology (ASTRO), October 18-21, San Antonio, TX.

4. Den RB, Yousefi K, Trock B, Davicioni E, Tosoian J, Thompson D, Choeurng V, Haddad Z, Tran PT, Trabulsi E, Gomella LG, Lallas CD, Abdollah F, Feng FY, Dicker AP, Freedland SJ, Karnes JR, Schaeffer EM, Ross AE: Efficacy of postoperative radiation in a prostatectomy cohort adjusted for clinical and genomic risk. Oral Presentation, 2016 Annual Meeting of the American Society for Radiation Oncology (ASTRO), September 25-28, 2016, Boston, Mass.

5. DiNome, J: Radiation Updates for Breast Cancer and Tidbits for the General Practitioner. Medical Grand Rounds, Riddle Hospital, Media PA, October, 2016.

6. Du S, Lockamy VL, Zhou L, Xue C, LeBlanc J, Yu Y, Dicker AP, Lu B: Stereotactic body

radiation therapy (SBRT) using a Sarrp for treating and monitoring therapy response in spontaneous Kras-driven lung tumor model. Poster Presentation, 2016 Annual Meeting of the American Society for Radiation Oncology (ASTRO), September 25-28, 2016, Boston, Mass.

7. Du S, Zhou L, Shukla G, Wang N, Yang L, Ma X, Wang Y, Dicker AP, Lu Y, Lu B:

Pharmacological inhibition of PD-1 exacerbates radiation-induced cardiac toxicity through

cytotoxic T cell-mediated myocarditis. Oral Presentation, 2016 Annual Meeting of the American Society for Radiation Oncology (ASTRO), September 25-28, 2016, Boston, Mass.

8. Fisher SA: Financial Planning for a Career in Radiation Oncology, Parts 1 and 2. Lectures held for Radiation Oncology Residents at Jefferson (every other year). In 2016, made this a Webinar to include Residents from the University of Virginia, University of Pittsburgh Medical Center, University of California, San Francisco, University of California, Davis, and the Ohio State University. June 23-24, 2016, Philadelphia, PA

9. Garg S, Palmer JD, Kim H, Williams NL, Bhamidipati D, Skowronski J, Glass J, Werner-Wasik M, Kim L, Shi W: Hypofractionated radiation therapy with concurrent temozolamide for recurrent high-grade glioma. Poster Presentation, 2016 Annual Meeting of the American Society for Radiation Oncology (ASTRO), September 25-28, 2016, Boston, Mass.

10. Giaddui T, Hardin M, Keller J, Kremmel E, Fu M, Peng C, Doyle L, Yu Y, Xiao Y. Harrison A: Analysis of Patient Specific QA for VMAT by Disease Site and Planning-Delivery System Using the ScandiDos Delta4 Phantom. Poster Presentation, 2015 Meeting of the AAPM, July 12-16, Anaheim, CA

11. Giaddui T, Jacobs P, Yu J, Manfredi D, Linnemann N , Xiao Y. Quantitative Evaluation of 2D-2D and 2D-3D Image Guided Radiation Therapy for Clinical Trial Credentialing, NRG Oncology/RTOG. Oral Presentation, 2015 AAPM, July 12-16, Anaheim, CA.

12. Giaddui TG, Yu J, Yua L, Chen W, Lin L, Simone II CB, Mohan R, Zhang X, Bluett J, Gillin MT, Liao Z, Moor K, Bradley JD, Martin-O’Meara E, Presley J, Galvin JM, Wu QRJ, Xiao Y: Evaluation of lung IMRT plans quality using a knowledge-based engineering tool. Oral Presentation, Annual Meeting of the American Society for Radiation Oncology (ASTRO), October 18-21, San Antonio, TX.

13. Giaddui T, Yu J, Doemer AJ, Matruszak MM, Nunez F, Vinegerg KA, Xia P, Yom SS, Xiao Y: On the feasibility of the dosimetric compliance criteria of NRG-HN002: A randomized Phase II trial for patients with p16 positive, non-smoking associated, locoregionally advanced oropharyngeal cancer. Poster Presentation, 2015 Annual Meeting of the American Society for Radiation Oncology (ASTRO), October 18-21, San Antonio, TX.

14. Giaddui T, Bollinger D, Glick A, Zhong H, Phillips H, Nunez F, Infante R, Hames S, Linnemann N, Lee R, Tak-Cheung Chan A, Yom SS, Hara W, Baxi SS, Chakravarti A, Lee N, Xia P, Xioa Y: Toward improving treatment planning quality and efficiency using knowledge engineering and autoplanning: A study based on NRG-HN001 clinical trial. Poster Presentation, 2016 Annual Meeting of the American Society for Radiation Oncology (ASTRO), September 25-28, 2016, Boston, Mass.

15. Giaddui T, Glock A, Bollinger D, Zhong H, Phillips H, Nunez F, Infante R, Hames S, Linneman N, Elder E, Chen J, Waldron JN, Trotti A, Thorstad WL, Schaner PE, Chakravarti A, Yom SS, Xia P, Xiao Y: Improving treatment planning quality, consistency and efficiency using rapid and autoplanning: A Feasibility study based on the NRG-HN002 clinical trial. Poster Presentation, 2016 Annual Meeting of the American Society for Radiation Oncology (ASTRO), September 25-28, 2016, Boston, Mass.

16. Gong Y, Yu J, Yeung V, Palmer J, Yu Y, Lu B, Babinsky L, Burkhart R, Leiby B, Siow V, Lavu H, Rosato E, Winter J, Lewis N, Sama A, Mitchell E, Anne` P, Hurwitz M, Yeo C, Bar-Ad V, Xiao Y: Artificial Neural Networks Applied to Overall Survival Prediction for Patients with

Periampullary Carcinoma. Poster Presentation, 2015 Meeting of the AAPM, July 12-16, Anaheim, CA.

17. Gong Y, Yu J, Xiao Y. On definition of minimum and maximum dose for target volume. Poster Presentation, 2015 Meeting of the AAPM, July 12-16, Anaheim, CA

18. Guo W, Du S, Yang L, Dicker AP, Lu B: Stat3 activation mediates stem cell, DNA repair, and immunosuppressive properties in crizotinib-resistance ELM4-ALK-rearranged lung cancer. Oral Presentation, 2016 Annual Meeting of the American Society for Radiation Oncology (ASTRO), September 25-28, 2016, Boston, Mass.

19. Hardin M, Harrison A, Lockamy V, Li J, Peng C, Potrebko P, Yu Y, Doyle L, Cao J:

Evaluation of the type and frequency of variations discovered during routine secondary patient chart review. Poster Presentation, 2015 Meeting of the AAPM, July 12-16, Anaheim, CA

20. Joseph, FM, Kumar M, Hutapea P, Dicker A, Yu Y, Podder T. Effects of Tissue Interference On Electromagnetic Sensor and Ultrasound Imaging Sensing for Robot-Guided Needle Interventions. Oral Presentation 2015 AAPM, July 12-16, Anaheim, CA

21. Joseph, FM, Yu Y, Podder T. Prostate HDR Brachytherapy with Multichannel Robotic system. Oral Presentation, 2015 Annual Meeting of the AAPM, July 12-16, Anaheim, CA

22. Kalchman I, Eldredge-Hindy HB, Hegarty SE, Ashamlla M, Keith SW, Werner-Wasik M: A pilot study of FDG PET lung uptake after thoracic radiation therapy and new pulmonary symptoms. Poster Presentation, 2016 Annual Meeting of the American Society for Radiation Oncology (ASTRO), September 25-28, 2016, Boston, Mass.

23. Keller J, Lockamy V, Glenn S, Harrison A. Novel Quality Assurance Procedure for the Small Animal Radiation Research Platform Using Commercial OSLDs. Poster Presentation, 2015 Meeting of the AAPM, July 12-16, Anaheim, CA

24. Keller J, Hardin M, Giaddui T, Kremmel E, Peng C, Doyle L, Yu Y, Harrison A. Analysis of Patient Specific VMAT QA Passing Rates with Delta4 for Matched Machines. Poster Presentation, 2015 Meeting of the AAPM, July 12-16, Anaheim, CA

25. Kim H, Dan TD, Palmer JD, Lawrence YR, Dicker AP: It’s about time: The paucity of reported follow-up and therapeutic endpoints in phase I drug-radiation therapy trials. Poster Presentation, 2015 Annual Meeting of the American Society for Radiation Oncology (ASTRO), October 18-21, San Antonio, TX.

26. Kim H, Kalchman I, Dan T, Zhan T, Werner-Wasik M: The influence of insurance policy on radiation oncology physician stereotactic body radiation therapy/stereotactic ablative radiation therapy use practices: A North American survey. Poster Presentation, 2016 Annual Meeting of the American Society for Radiation Oncology (ASTRO), September 25-28, 2016, Boston, Mass.

27. Kim H, Malatesta T. Bar Ad V, Anne` PR, McAna J, Den RB: Improving resident education

by providing continuing medical education (CME) and self-assessment module (SAM) credit to faculty in resident didactic sessions. Poster Presentation, 2016 Annual Meeting of the American Society for Radiation Oncology (ASTRO), September 25-28, 2016, Boston, Mass.

28. Kremmel E, Giaddui T, Keller J, Fu M, Peng C, Doyle L, Yu Y, Harrison A. Gamma Passing Rates for IMRT QA and VMAT QA. Poster Presentation, 2015 Meeting of the AAPM, July 12-16, Anaheim, CA

29. Li J , Shi W, Andrews D, Werner-Wasik M, Yu Y, Liu H. Comparison of Online Image Registrations of Varian TrueBeam Cone-Beam CT and BrainLab ExacTrac Imaging Systems. Poster Presentation, 2015 Meeting of the AAPM, July 12-16, Anaheim, CA

30. Liu H: Dosimetric validation for an automatic brain metastases planning element based on single isocenter dynamic conformal arcs. Oral presentation, Radiosurgery Society Meeting, June 16-18, 2016, Orlando, FL.

31. Liu H: Commissioning and IGRT requirements for multiple brain metastases SRS. Oral presentation, Novalis Circle Symposium at the AAPM Annual Meeting. July 31-August 4, 2016, Washington, DC

32. Lu B: The Smac mimetic Debio 1143 synergizes with radiotherapy and immune checkpoint

inhibitors to enhance antitumor immunity. Poster Presentation, 2015 Cold Spring Harbor Symposium, September 21-25, 2015, Cold Spring Harbor, NY.

33. Lucas JT, Serrano N, Kim H, Li Y, Hua CH, Broniscer A, Merchant TE, Shulkin B: 11C-Methionine positron emission tomography delineates non-contrast enhancing tumor regions at high risk for recurrence in pediatric high-grade glioma. Oral Presentation, International Symposium on Pediatric Neuro-Oncology, 17th Annual Meeting, Liverpool, England, June 12-15, 2016.

34. Mishra MV, Dan T, Louie A: Conditional survival probabilities following bladder preservation for patients with muscle invasive bladder cancer (MIBC). Oral Presentation (#51), 2015 Annual Meeting of the American Society for Radiation Oncology (ASTRO), October 18-21, San Antonio, TX.

35. Nowak K, Giaddui T, Palmer JD, Kim H, Lyschchik A, Bar Ad V: Reducing Resident inter-observer variability in thoracic organ at risk definition through educational interventions. Poster Presentation, 2015 Annual Meeting of the American Society for Radiation Oncology (ASTRO), October 18-21, San Antonio, TX.

36. Nowak K, Casey J, Chitale , Kalchmn I, Buss E, Keith SW, Hegarty SE, Curtis M, Solomides C, Shi W, Judy KD, Andrews DW, Farrell CJ, Werner-Wasik M: High KI67 labeling index in resected WHO grade 1 meningiomas correlates with a higher rate of recurrence. Poster Presentation, 2016 Annual Meeting of the American Society for Radiation Oncology (ASTRO), September 25-28, 2016, Boston, Mass.

37. Palmer JD, Barsoom R, Shukla G, Skowronski J, Andrews DW, Kim L, Glass J, Werner-

Wasik M, Farrell C, Shi W: Patterns of failure following re-irradiation in patients with recurrent high-grade glioma. Poster Presentation, 2015 Annual Meeting of the American Society for Radiation Oncology (ASTRO), October 18-21, San Antonio, TX.

38. Palmer J, Mehta M, Williams N, Dicker AP, Werner-Wasik M, Shi W: Treatment recommendations for elderly patients with newly diagnosed glioblastoma lack worldwide consensus. Oral Presentation, 2015 Society for Neuro-Oncology Scientific Meeting, November 19-22, 2015, San Antonio, TX

39. Palmer JD, Werner-Wasik M, Andrews DW, Evans J, Glass J, Kim L, Judy K, Farrell C, Bar Ad V, Simone NL, Dicker AP, Shi W: Phase 2, open-label, trial evaluating safety, tolerability, and preliminary antitumor activity of panobinostat and fractionated stereotactic reirradiation therapy for recurrent high-grade gliomas. Oral Presentation, 2015 Society for Neuro-Oncology Scientific Meeting, November 19-22, 2015, San Antonio, TX

40. Palmer JD, Shukla G, Bhamidipati D, Skowronski J, Kim H, Judy KD, Evans JJ, Farrell CJ, Andrews DW, Kim L, Glass J, Werner-Wasik M, Shi W: Early tumor progression prior to adjuvant therapy may predict survival in newly-diagnosed glioblastoma. Poster Presentation, 2016 Annual Meeting of the American Society for Radiation Oncology (ASTRO), September 25-28, 2016, Boston, Mass.

41. Shi W, Scannell BM, Gilbert MR, Mehta MP, Blumenthal DT, Brown PD, Valeinis E, Hopkins K, Souhami L, Andrews DW, Howard SP, Youseef EF, Lessard N, Dignam J, Werner-Wasik M: Investigating the effect of reirradiation oor systemic therapy in patients with GBM after tumor progression: a secondary analysis of the NRG Oncology/RTOG 0525. Society for Neuro-Oncology Scientific Meeting, November 19-22, 2015, San Antonio, TX

42. Shi W, Siglin J, Palmer JD, Champ CE, Dan TD, Werner-Wasik M, Glass J, Kim L, Evans JJ, Judy K, Farrell C, Andrews DW: Fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment. Poster Presentation, 2015 Annual Meeting of the American Society for Radiation Oncology (ASTRO), October 18-21, San Antonio, TX.

43. Shukla G, Palmer JD, Werner-Wasik M: Outcomes after whole brain re-irradiation for brain metastases: A single institution experience. Poster Presentation, 2015 Annual Meeting of the American Society for Radiation Oncology (ASTRO), October 18-21, San Antonio, TX.

44. Shukla G, Palmer JD, Glass J, Kim L, Shi W: Outcomes after stereotactic radiation therapy for primary CNS lymphoma. Poster Presentation, 2016 Annual Meeting of the Society for Neuro-Oncology, November 17-20, 2016, Scottsdale, AZ.

45. Shukla G, Palmer JD, Li T, Lockamy V, Peng C, Shi W: Placement of scalp electrodes (Novo TTF) does not significantly change radiation dosimetry when delivering cranial intensity modulated radiation therapy (IMRT). Poster Presentation, 2016 Annual Meeting of the Society for Neuro-Oncology, November 17-20, 2016, Scottsdale, AZ.

46. Simone BA, Dan T, Palagani A, DeAngelis T, Schiewer M, Knudsen KE, Dicker AP, Simone NL: Caloric restriction augments the molecular effects of radiation in both hormone-sensitive and hormone-insensitive prostate cancers by decreasing inflammation. Oral Presentation, 2016 Annual Meeting of the American Society for Radiation Oncology (ASTRO), September 25-28, 2016, Boston, Mass.

47. Troeller A, Soehn M, Grills I, Guckenberger M, Belderbos J, Sonke J, Hope A, Werner-Wasik M, Xiao Y, Yan D. Investigation of Fractionation Issues in NTCP Modeling of Pneumonitis: An Analysis of Common NTCP Models for Hypo-Fractionated and Standard-Fractionated Data. Oral Presentation, 2015 Annual Meeting of the AAPM, July 12-16, Anaheim, CA

48. Vasilakopoulou M, Won M, Curran WJ, Souhami L, Prados MD, Langer CJ, Rimm DL, Hanna

JA, Neumeister VM, Small W, Cobleigh MA, Atkins JN, Komarnicky L, Schultz CJ, Howard SP, Dicker AP, Knisely J: BRCA protein expression predicts survival in glioblastoma patients from

a RTOG cohort. Oral Presentation, 2015 Annual Meeting of the American Society for Radiation Oncology (ASTRO), October 18-21, San Antonio, TX.

49. Williams NL, Marquess M, Giordano C, Johnston S, Den RB: A pilot study demonstrating the utility of a virtual reality education model in reducing anxiety and increasing comprehension for patients receiving radiation therapy. American College of Radiology, March 17-19, 2016, Orlando, FL.

50. Williams NL, Rivera AC, Hardin MT, Palmer JD, Doyle LA, Harrison AS, Peng C, Lallas

CD, Trabulsi EJ, Gomella LG, Hurwitz MD, Dicker AP, Den RB: Phase I study of high dose rate brachytherapy combined with hypofractionated volumetric modulated arc therapy for intermediate risk prostate cancer. Poster Presentation, 2015 Annual Meeting of the American Society for Radiation Oncology (ASTRO), October 18-21, San Antonio, TX.

51. Williams NL, Kim H, Eldredge-Hindy HB, Feeney KJ, Mastrangelo MJ, Sato T, Kim L, Evans JJ, Farrell CJ, Judy KD, Andrews DW, Dicker AP, Werner-Wasik M, Wuthrick EJ, Shi W: Phase I study of ipilimumab combined with whole-brain radiation therapy or radiosurgery for melanoma patients with brain metastases. e-Poster Presentation, 2016 Annual Meeting of the American Society for Radiation Oncology (ASTRO), September 25-28, 2016, Boston, Mass.

52. Yu J, Gong Y, Bar-Ad V, Giaddui T, Hu C, Gore E, Wheatley M, Witt J, Robinson C, Kong F-M, Bradley J, Galvin J, Xiao Y. Optimizing Technical Parameters for Using Atlas Based Automatic Segmentation for Evaluation of Contour Accuracy – Experience with Cardiac Structures from NRG Oncology/RTOG 0617. Poster Presentation, 2015 Meeting of the AAPM, July 12-16, Anaheim, CA

53. Zaorsky NG, Keith SW, Dicker AP, Horwitz EM, Den RB: Evaluation of a biologically

equivalent dose escalation and patient outcomes among international randomized controlled trials of conventionally fractionated and hypofractionated radiation therapy: A meta-analysis of 6,800 patients. Poster Presentation, 2015 Annual Meeting of the American Society for Radiation Oncology (ASTRO), October 18-21, San Antonio, TX.

54. Zhang HH, Zhang P, Gilbert M, Aldape K, Chakravarti A, Agliocco A, Klimowicz AC, Souza WD, Corn BW, Hunter GK, Muanza TM, Dicker AP, Vigneault E, Brachman DG, Bovi JA, Robins I, Sahijdak WM, Won M, Mehta MP: NRG Oncology/RTOG 0525 survival predictability of composite clinical parameters and protein biomarkers based on machine learning. Oral Presentation (#324) 2015 Annual Meeting of the American Society for Radiation Oncology (ASTRO), October 18-21, San Antonio, TX.

COMMITTEE APPOINTMENTS: JEFFERSON Jessie DiNome, M.D.: Committee on Continuing Medeical Education, Sidney Kimmel Medical College at Thomas Jefferson University, September, 2016. Eric L. Gressen, M.D.: Appointed to the JeffCare Credentialing Committee, Jefferson Health System, July, 2015. Eric L. Gressen, M.D.: Appointed to the Affiliations Committee, Sidney Kimmel Medical College at Thomas Jefferson University, July, 2015.

Shari B. Rudoler, M.D.: Appointed to the Oncology Steering Committee, Aria Health, 2015 Shari B. Rudoler, M.D.: Appointed to the Committee on Affiliations, Sidney Kimmel Medical College at Thomas Jefferson University, July, 2015 Shari B. Rudoler, M.D.: Appointed to the Nominating Committee, Sidney Kimmel Medical College at Thomas Jefferson University, July, 2015. Wenyin Shi, M.D., Ph.D.: Appointed to the Committee on Professionalism, Sidney Kimmel Medical College at Thomas Jefferson University, September, 2016 Maria Werner-Wasik, M.D.: Member, Jefferson Clinical Research Institute (JCRI), 2015. Maria Werner-Wasik, M.D.: Co-Leader, Aerodigestive Cancers Multidisciplinary Group, 2015. Maria Werner-Wasik, M.D.: Senior Physician Leader, Clinical Trial Office, Sidney Kimmel Cancer Center, 2016. NATIONAL Adam P. Dicker, M.D., Ph.D.: Appointed to the Program Committee, American Association for Cancer Research Annual Meeting, 2016. Adam P. Dicker, M.D., Ph.D.: Appointed FY 2016 Chair, Prostate Cancer Research Program (PCRP) Integration Panel, Department of Defense.

Adam P. Dicker, M.D., Ph.D.: Member, National Clinical Trials Network Core Correlative Sciences Committee (2015-2017), National Institutes of Health. Laura Doyle, M.S.: Member, Online Learning Services Subcommittee, American Association of Physicists in Medicine, August, 2016 – December, 2019. Eric Gressen, M.D.: Vice Chair, History Committee of the Board of Directors for the American Society for Radiation Oncology (ASTRO), 2015 Nicole Simone, M.D.: Appointed to the Breast Committee (three-year term), NRG Oncology, July, 2015. Nicole Simone, M.D.: Appointed to the Translational Subcommittee (three-year term), NRG Oncology, July, 2015. Maria Werner-Wasik, M.D.: Chair, Lung track Abstract Review Panel, 2015 ASTRO Annual Meeting. Maria Werner-Wasik, M.D.: Lung Track Chair, Best of ASTRO, 2016 Annual Meeting Scientific Committee. Yan Yu, Ph.D., M.B.A.: Appointed Chair, NIH-CSR SBIB F(56)r Early Phase Clinical Trials in Imaging and Image-guided Interventions (RO1) review panel, 2015.

HONORS AND AWARDS:

Faculty: P. Rani Anne`, M.D.: Selected as a Philadelphia Magazine 2016 “Top Doc”, April , 2016. Voichita Bar Ad, M.D.: Selected to receive the Sidney Kimmel Medical College Dean’s Award for Excellence in Education, May, 2016. Robert Den, M.D. and Mark Hurwitz, M.D.: Selected to receive the Sidney Kimmel Medical College Faculty Team Achievement Award, May, 2016. Adam P. Dicker, M.D., Ph.D.: Selected as a Philadelphia Magazine 2016 “Top Doc”, April , 2016. Adam P. Dicker, M.D., Ph.D.: Appointed Senior Vice President and Chair, Enterprise Radiation Oncology at Thomas Jefferson University, October, 2016. Jessie DiNome, M.D.: Selected as a “Top Doc: in Radiation Oncology. Mainline Magazine, 2015. Amy S. Harrison, M.S.: Elected President of the Delaware Valley Chapter of the American Association of Physicists in Medicine (October, 2016). Cheng Peng, Ph.D.: Re-elected as Secretary of the Delaware Valley Chapter of the American Association of Physicists in Medicine (October, 2016). Wenyin Shi, M.D., Ph.D.: Appointed Editor, Central Nervous System Tumours, 2016. Wenyin Shi, M.D., Ph.D.: Selected as a Philadelphia Magazine 2016 “Top Doc”, April , 2016. Nicole Simone, M.D.: Selected to receive the Sidney Kimmel Medical College Early Career Investigator Award for Distinguished Achievement in Biomedical Research, May, 2016 Paul Stauffer, MSEE: 2016 Class of the Thomas Jefferson University Chapter of the National Academy of Inventors (NAI), June 30,2016. Paul Stauffer, MSEE: Distinguished Mentor Award 2016 Certificate of Recognition, (Post-doctoral fellows. Presented by Lis M. Kozlowski, Ph.D., Associate Dean for Student and Postdoctoral Affairs, Jefferson College of Biomedical Sciences at Thomas Jefferson University), September 19, 2016. Maria Werner-Wasik, M.D.: Selected as a Philadelphia Magazine 2016 “Top Doc”, April , 2016. Maria Werner-Wasik, M.D.: Promoted to Executive Vice Chair for Integration at Thomas Jefferson University, October, 2016. Yan Yu, Ph.D., M.B.A.: Selected Fellow, American Society for Radiation Oncology (ASTRO), ASTRO 57th Annual Meeting, San Francisco, CA, October 18-21, 2015. Yan Yu, Ph.D., M.B.A.: Selected to receive the Michael and Melina Pellini Award for Innovation in the Biomedical Sciences (Sidney Kimmel Medical College), May, 2016.

Yan Yu, Ph.D., M.B.A.: 2016 Class of the Thomas Jefferson University Chapter of the National Academy of Inventors (NAI), June 30,2016. Yan Yu, Ph.D., M.B.A.: Invited External Scientific Reviewer for Hefei Proton Therapy Project, Hefei Ion Medical Center, China.

Residents: Tawfik Giaddui, PhD: Abstract won the 2nd place, Physics, in the Resident Poster Viewing Recognition Award for abstract entitled, “Improving treatment planning quality, consistency and efficiency using rapid and auto planning: a feasibility study based on the NRG-HN002 clinical trial”. 2016 ASTRO Annual Meeting, September 25-28, 2016, Boston, MA. Hyun Kim, M.D.: Selected for the American Brachytherapy Society (ABS)/Elekta/Varian joint sponsored HDR Brachytherapy Scholarship Program for 2016. Will spend a week at the Sunnybrook Odette Cancer Centre in Toronto, Canada during 2016. Kamila Nowak Choi, M.D.: Abstract won the 3rd place, Biology, in the Resident Poster Viewing Recognition Award for abstract entitled, “High Ki67 labeling index in resected WHO grade 1 meningiomas correlates with a higher rate of recurrence. She will give an oral presentation during the poster reception for this abstract. 2016 ASTRO Annual Meeting, September 25-28, 2016, Boston, MA. Noelle Williams, M.D.: 2016 Alpha Omega Alpha Postgraduate Award for: A pilot feasibility trial examining the use of electronic patient-reported outcomes in prostate cancer patients with Apple ResearchKit Smartphone Application. August, 2016.

Administration:

Alex Khariton: Recipient of the 2016 Distinguished Service Award from the Society of Radiation Oncology Administrators, October, 2016.

GRANTS: Wenyin Shi, MD, PhD., Principal Investigator: Pilot study of scalp sparing radiation with concurrent and maintenance temozolomide and Optune for patients with newly diagnosed GBM. Source of Funding: Novocure, 2016-2018. Wenyin Shi, MD, PhD., Principal Investigator: Investigation of Optune® on GBM radiation treatment planning. Source of Funding: Novocure, 2016. CLINICAL TRIALS: Wenyin Shi, MD, PhD., Institutional Principal InvestIgator: Whole-brain radiation therapy with or without hippocampal avoidance in treatment patients with limited stage or extensive stage small cell lung cancer. Clinical trials gov. Identifier: NCT02635009